1. |
He Y, Jiang Y, Wang J, et al. Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China. J Vasc Surg 2006; 44:333-8.
|
2. |
Guan H, Liu ZM, Li GW, et al. The relative factor analysis of the peripheral artery obstructive disease in diabetes over 50 years. Chin J Med 2007; 87:23-7.
|
3. |
Clair D, Shah S, Weber J. Current state of diagnosis and management of critical limb ischemia. Curr Cardiol Rep 2012; 14:160-70.
|
4. |
Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M, et al. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplant 2011; 20:1629-39.
|
5. |
Qazi Y, Stagg B, Singh N, et al. Nanoparticles-mediated delivery of shRNA VEGF-A plasmids regresses corneal neovascularization. Invest Ophthalmol Vis Sci 2012; 53:2837-44.
|
6. |
Thurston G, Rudqe JS, Zhou H, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature Med 2000; 6:460-3.
|
7. |
Smith AH, Kuliszewski MA, Liao C, et al. Sustained im-provement in perfusion and flow reserve after temporally separated delivery of VEGF and angiopoietin-1 plasmid deoxyribonucleic acid. J Am Coll Cardiol 2012; 59:1320-8.
|
8. |
Eduardo HY, Roberta SS, Samoto VY, et al. Treatment of mouse limb ischemia with an integrative hypoxia- responsive vector expressing the vascular endothelial growth factor gene. PLoS One 2012; 7:1-6.
|
9. |
Rebar EJ, Huang Y, Hickey R, et al. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 2002; 11:1427-32.
|
10 |
Snowden AW, Zhang L, Urnov F, et al. Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors. Cancer Res 2003; 63:8968-76.
|
11 |
Chen G, Tian X, Liu Z, et al. Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-Ⅲ isoform expression. Br J Cancer 2010; 102:188-195.
|
12 |
Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-4.
|
13 |
Rajagopalan S, Mohler Ⅲ ER, Lederman RJ, et al. Regional angiogenesis with VEGF in peripheral arterial disease: a phase Ⅱ randomized, double-blind, controlled study of adenoviral delivery of VEGF121 in patients with disabling intermittent claudication. Circulation 2003; 108:1933-8.
|
14 |
Kang YA, Shin HC, Yoo JY, et al. Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus. Mol Ther 2008; 16:1033-40.
|
15 |
Xie D, Li Y, Reed EA, et al. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia. J Vasc Surg 2006; 44:166-75.
|
16 |
Yang YG, Guan H, Liu CW, et al. Reinstate the damaged VEGF signaling pathway with VEGF-activating transcription factor. Chin Med Sci J 2009; 24:186-90.
|
17 |
Kusumanto YH, Van Weel V, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 2006; 17:683-91.
|
18 |
Cristofaro B, Stone OA, Caporali A, et al. Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neo-vascularization in a mouse model of limb ischemia. Arterioscler Thromb Vasc Biol 2010; 30:1143-50.
|
19 |
Liu Y, Figley S, Spratt SK, et al. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol Dis 2010; 37:384-93.
|
20 |
Yu J, Lei L, Liang Y, et al. An engineered VEGF-activating zinc figure protein transcription factor improves blood flow and limb salvage in advanced-age mice. FASEB J 2006; 20:479-81.
|
21 |
Dent CL, Lau G, Drake EA, et al. Regulation of endogenous gene expression using small molecule-controlled engineered zinc-finger protein transcription factors. Gene Ther 2007; 14:1362-9.
|
22 |
Zhang HS, Liu D, Huang Y, et al. A designed zinc-finger transcriptional repressor of phospholamban improves function of the failing heart. Mol Ther 2012; 20:1508-15.
|
23 |
Makarevich P, Tsokolaeva Z, Shevelev A, et al. Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. PLoS One 2012; 7:e38776.
|